Back to results list
Please use this identifier to cite or link to this item:
|Title:||Tracking development assistance for health from China, 2007-2017||Authors:||Micah, AE
|Issue Date:||2019||Publisher:||BMJ Group||Source:||BMJ global health, 2019, v. 4, no. 5, e001513 How to cite?||Journal:||IOP conference series : materials science and engineering||Abstract:||Introduction In recent years, China has increased its international engagement in health. Nonetheless, the lack of data on contributions has limited efforts to examine contributions from China. Existing estimates that track development assistance for health (DAH) from China have relied primarily on one dataset. Furthermore, little is known about the disbursing agencies especially the multilaterals through which contributions are disbursed and how these are changing across time. In this study, we generated estimates of DAH from China from 2007 through 2017 and disaggregated those estimates by disbursing agency and health focus area.
Methods We identified the major government agencies providing DAH. To estimate DAH provided by each agency, we leveraged publicly available development assistance data in government agencies' budgets and financial accounts, as well as revenue statements from key international development agencies such as the WHO. We reported trends in DAH from China, disaggregated contributions by disbursing bilateral and multilateral agencies, and compared DAH from China with other traditional donors. We also compared these estimates with existing estimates.
Results DAH provided by China grew dramatically, from US$323.1 million in 2007 to $652.3 million in 2017. During this period, 91.8% of DAH from China was disbursed through its bilateral agencies, including the Ministry of Commerce ($3.7 billion, 64.1%) and the National Health Commission ($917.1 million, 16.1%); the other 8.2% was disbursed through multilateral agencies including the WHO ($236.5 million, 4.1%) and the World Bank ($123.1 million, 2.2%). Relative to its level of economic development, China provided substantially more DAH than would be expected. However, relative to population size and government spending, China's contributions are modest.
Conclusion In the current context of plateauing in the growth rate of DAH contributions, China has the potential to contribute to future global health financing, especially financing for health system strengthening.
|URI:||http://hdl.handle.net/10397/81631||ISSN:||2059-7908||EISSN:||2059-7908||DOI:||10.1136/bmjgh-2019-001513||Rights:||© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
The following publication : Micah AE, Zhao Y, Chen CS, et al. Tracking development assistance for health from China, 2007–2017. BMJ Global Health 2019;4:e001513, is available at https://doi.org/10.1136/bmjgh-2019-001513
|Appears in Collections:||Journal/Magazine Article|
Show full item record
Files in This Item:
|Micah_Tracking_development_assistance.pdf||1.13 MB||Adobe PDF||View/Open|
Citations as of Feb 12, 2020
Citations as of Feb 12, 2020
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.